Teveten (eprosartan mesylate)
/ Abbott
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 08, 2021
metabolic: Effect of Losartan or Eprosartan on Fructose Hyperuricemia
(clinicaltrials.gov)
- P=N/A; N=16; Completed; Sponsor: Medical University of Lodz
Clinical • New trial • Metabolic Disorders
May 19, 2020
CLARITY: Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
(clinicaltrials.gov)
- P4; N=605; Not yet recruiting; Sponsor: The George Institute
New P4 trial • Novel Coronavirus Disease • Respiratory Diseases
1 to 2
Of
2
Go to page
1